Literature DB >> 24366254

The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Pradeep Bist1, Neha Dikshit, Tse Hsien Koh, Alessandra Mortellaro, Thuan Tong Tan, Bindu Sukumaran.   

Abstract

Acinetobacter baumannii is a major extensively drug-resistant lethal human nosocomial bacterium. However, the host innate immune mechanisms controlling A. baumannii are not well understood. Although viewed as an extracellular pathogen, A. baumannii can also invade and survive intracellularly. However, whether host innate immune pathways sensing intracellular bacteria contribute to immunity against A. baumannii is not known. Here, we provide evidence for the first time that intracellular antibacterial innate immune receptors Nod1 and Nod2, and their adaptor Rip2, play critical roles in the sensing and clearance of A. baumannii by human airway epithelial cells in vitro. A. baumannii infection upregulated Rip2 expression. Silencing of Nod1, Nod2, and Rip2 expression profoundly increased intracellular invasion and prolonged the multiplication and survival of A. baumannii in lung epithelial cells. Notably, the Nod1/2-Rip2 axis did not contribute to the control of A. baumannii infection of human macrophages, indicating that they play cell type-specific roles. The Nod1/2-Rip2 axis was needed for A. baumannii infection-induced activation of NF-κB but not mitogen-activated protein kinases. Moreover, the Nod1/2-Rip2 axis was critical to induce optimal cytokine and chemokine responses to A. baumannii infection. Mechanistic studies showed that the Nod1/2 pathway contributed to the innate control of A. baumannii infection through the production of β-defensin 2 by airway epithelial cells. This study revealed new insights into the immune control of A. baumannii and may contribute to the development of effective immune therapeutics and vaccines against A. baumannii.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24366254      PMCID: PMC3958010          DOI: 10.1128/IAI.01459-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.

Authors:  David A Hunstad; Sheryl S Justice
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 2.  The protein Nod2: an innate receptor more complex than previously assumed.

Authors:  Aurore Lecat; Jacques Piette; Sylvie Legrand-Poels
Journal:  Biochem Pharmacol       Date:  2010-07-17       Impact factor: 5.858

3.  Synergism of NOD2 and NLRP3 activators promotes a unique transcriptional profile in murine dendritic cells.

Authors:  Cristina Conforti-Andreoni; Ottavio Beretta; Ginevra Licandro; Hong Liang Qian; Matteo Urbano; Federico Vitulli; Paola Ricciardi-Castagnoli; Alessandra Mortellaro
Journal:  J Leukoc Biol       Date:  2010-09-30       Impact factor: 4.962

Review 4.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors:  George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

5.  Receptor interacting protein-2 contributes to host defense against Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Yasunori Ogura; Joao H F Pedra; Koichi S Kobayashi; Richard A Flavell; Erol Fikrig
Journal:  FEMS Immunol Med Microbiol       Date:  2012-07-23

6.  Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands.

Authors:  Joao G Magalhaes; Jooeun Lee; Kaoru Geddes; Stephen Rubino; Dana J Philpott; Stephen E Girardin
Journal:  Eur J Immunol       Date:  2011-04-12       Impact factor: 5.532

7.  Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37.

Authors:  Jennifer H Moffatt; Marina Harper; Ashley Mansell; Bethany Crane; Timothy C Fitzsimons; Roger L Nation; Jian Li; Ben Adler; John D Boyce
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

8.  Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Wangxue Chen
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

Review 9.  Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.

Authors:  Mathias Chamaillard; Stephen E Girardin; Jérôme Viala; Dana J Philpott
Journal:  Cell Microbiol       Date:  2003-09       Impact factor: 3.715

10.  Differences in Acinetobacter baumannii strains and host innate immune response determine morbidity and mortality in experimental pneumonia.

Authors:  Anna de Breij; Matthieu Eveillard; Lenie Dijkshoorn; Peterhans J van den Broek; Peter H Nibbering; Marie-Laure Joly-Guillou
Journal:  PLoS One       Date:  2012-02-08       Impact factor: 3.240

View more
  24 in total

1.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 2.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 3.  The Role of Nucleotide-Binding Oligomerization Domain-Like Receptors in Pulmonary Infection.

Authors:  Kristin M Wiese; Bria M Coates; Karen M Ridge
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

4.  Current advances and challenges in the development of Acinetobacter vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2.

Authors:  Madelyn H Miller; Michael G Shehat; Justine T Tigno-Aranjuez
Journal:  Immunohorizons       Date:  2020-12-18

6.  Epithelial innate immune response to Acinetobacter baumannii challenge.

Authors:  Zhimin Feng; Xun Jia; Mark D Adams; Santosh K Ghosh; Robert A Bonomo; Aaron Weinberg
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

Review 7.  Innate Immune Responses to Acinetobacter baumannii in the Airway.

Authors:  Sílvia Pires; Dane Parker
Journal:  J Interferon Cytokine Res       Date:  2019-04-23       Impact factor: 2.607

Review 8.  Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

Authors:  A M Richards; Y Abu Kwaik; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2014-09-27       Impact factor: 3.563

9.  Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.

Authors:  Michael J Noto; Kelli L Boyd; William J Burns; Matthew G Varga; Richard M Peek; Eric P Skaar
Journal:  Infect Immun       Date:  2015-08-03       Impact factor: 3.441

Review 10.  Uncovering the mechanisms of Acinetobacter baumannii virulence.

Authors:  Christian M Harding; Seth W Hennon; Mario F Feldman
Journal:  Nat Rev Microbiol       Date:  2017-12-18       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.